NCT07089966 HIV Testing Counselor-led Care to Catalyze Integration of PrEP Delivery in Family Planning Clinics
| NCT ID | NCT07089966 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Washington |
| Condition | Human Immunodeficiency Virus (HIV) |
| Study Type | INTERVENTIONAL |
| Enrollment | 30,000 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30,000 participants in total. It began in 2025-12-01 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a cluster randomized, stepped wedge implementation study to introduce HIV testing services (HTS) counselor-led PrEP care in public health clinics in Kenya.
Eligibility Criteria
Inclusion Criteria: * ≥15 years of age * Accessing health services at participating public health facilities. * Not known to be living with HIV prior to the visit when their clinical data is first abstracted
Contact & Investigator
Kenneth Mugwanya, MBChB, MS, PhD
PRINCIPAL INVESTIGATOR
University of Washington
Frequently Asked Questions
Who can join the NCT07089966 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, studying Human Immunodeficiency Virus (HIV). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07089966 currently recruiting?
Yes, NCT07089966 is actively recruiting participants. Contact the research team at brownce@uw.edu for enrollment information.
Where is the NCT07089966 trial being conducted?
This trial is being conducted at Kisumu, Kenya.
Who is sponsoring the NCT07089966 clinical trial?
NCT07089966 is sponsored by University of Washington. The principal investigator is Kenneth Mugwanya, MBChB, MS, PhD at University of Washington. The trial plans to enroll 30,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.